Pulse Biosciences Inc.

PLSE | NASDAQ

Price Alert Chart Builder DCF Calculator

$53.45

+$1.21 (+2.32%)

Nov 2, 2026, 11:42 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-72.78M	-53.59M	-42.21M	-58.51M	-63.66M	-49.85M
Depreciation & Amortization	1.07M	1.18M	1.21M	1.36M	1.15M	1.1M
Stock-Based Compensation	21.46M	13.59M	7.18M	5.19M	14.6M	10.08M
Other Working Capital	-5.74M	2.63M	396K	221K	-1.47M	3.47M
Other Non-Cash Items	1.15M	6K	13K	8.66M	13K	116K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-5.02M	2.47M	768K	-3.72M	-6.2M	3.2M
Operating Cash Flow	-54.12M	-36.34M	-33.04M	-47.01M	-54.1M	-35.37M
Capital Expenditures	-315K	-125K	-121K	-401K	-437K	-441K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	-10.49M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-29.03M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	8M	39.51M
Other Investing Acitivies	-20K	n/a	n/a	n/a	n/a	10.49M
Investing Cash Flow	-335K	-125K	-121K	-401K	7.56M	10.04M
Debt Repayment	n/a	n/a	n/a	65M	407K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	50.49M	-6K	75K	62.51M	1.45M
Financial Cash Flow	17.15M	110.14M	16.39M	79.94M	62.69M	30.89M
Net Cash Flow	-37.3M	73.67M	-16.77M	32.53M	16.15M	5.56M
Free Cash Flow	-54.44M	-36.47M	-33.16M	-47.41M	-54.53M	-35.81M
Adj. Free Cash Flow	-75.89M	-50.05M	-40.34M	-52.61M	-69.14M	-45.88M
Maintenance CapEx	n/a	-125K	-121K	-401K	n/a	-441K
Growth CapEx	-315K	n/a	n/a	n/a	-437K	n/a
Owner Earnings	-54.12M	-36.47M	-33.16M	-47.41M	-54.1M	-35.81M